EGFR and glioblastoma: Glioblastomas cells with mutant IDH1, IDH2, and CpG island methylator phenotype (CIMP) showed remarkable alteration in the expression of variant genes, including WNT, epidermal growth factor receptor (EGFR), transforming growth factor-β (TGFβ), RAS, and angiogenesis-related genes.